Oral solid dose manufacturing remains a mainstay of the pharmaceutical industry, but today’s products are placing new demands on development, containment, technology transfer, and commercial supply. This eBook brings together insights from Pfizer CentreOne on managing that complexity—from selecting the right manufacturing site and scaling specialized processes to navigating the regulatory and operational requirements of highly potent compounds. It also provides an inside look at the capabilities and expertise supporting OSD programs across Pfizer CentreOne’s global manufacturing network.
In this eBook, you’ll learn to:
Navigate the complexities of oral solid dose manufacturing.
Select a manufacturing provider for complex OSD products.
Manage highly potent compounds with specialized technologies and containment.
Support reliable tech transfer, scale-up, and commercialization.
Bruno Sciamanna and Lillian Glennon of Pfizer CentreOne discuss the market forces shaping oral solid dose manufacturing and what sponsors should look for in a commercial manufacturing partner.
How Pfizer CentreOne helps customers navigate complexity in OSD manufacturing through a consistent network and targeted technical expertise at the site level.
